Overview: In April 2020 Canada's Packaged Medicaments exports accounted up to C$1.41B and imports accounted up to C$1.37B, resulting in a positive trade balance of C$40.1M. Between April 2019 and April 2020 the exports of Canada's Packaged Medicaments have decreased by C$-214M (-13.2%) from C$1.62B to C$1.41B, while imports increased by C$186M (15.7%) from C$1.18B to C$1.37B.
Destinations: In April 2020 Packaged Medicaments exported mostly to United States (C$1.04B), Italy (C$154M), Japan (C$92M), China (C$11M), and France (C$9.75M), and imported mostly from United States (C$599M), Switzerland (C$160M), Germany (C$93M), Ireland (C$53.5M), and United Kingdom (C$51.5M).
Growth: In April 2020, the decrease in Packaged Medicaments's year-by-year exports was explained primarily by a decrease in exports to United States (C$-360M or -25.7%), Taiwan (C$-9.43M or -78.9%), and France (C$-3.78M or -27.9%). In April 2020, the increase in Packaged Medicaments's year-by-year imports was explained primarily by an increase in imports from United States (C$173M or 40.6%), Switzerland (C$26.3M or 19.7%), and United Kingdom (C$18.9M or 57.9%).